Neogenomics Inc.

NASDAQ: NEO
Share price (4/24/24): $14.03
Market cap (4/24/24): $1.791 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

5 Neogenomics Inc. Expert Interviews, now on BamSEC.

Powered by Tegus.

Indentures Filter

from 8-K 106 pages Neogenomics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of January 11, 2021 0.25% Convertible Senior Notes Due 2028

from S-3ASR 106 pages Neogenomics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of January [ ], 2021 [ ]% Convertible Senior Notes Due 2028

from 8-K 103 pages Neogenomics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of May 4, 2020 1.25% Convertible Senior Notes Due 2025

from S-3ASR 103 pages Neogenomics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of May [●], 2020 [●]% Convertible Senior Notes Due 2025

from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from S-8 18 pages Neogenomics, Inc. Amended and Restated Equity Incentive Plan Amended and Restated Effective as Of: April 16, 2013 Neogenomics, Inc. Amended and Restated Equity Incentive Plan

from S-8 10 pages Neogenomics, Inc. Employee Stock Purchase Plan Originally Effective October 31, 2006 as Amended and Restated April 16, 2013

from 8-K 9 pages Neogenomics, Inc. Equity Incentive Plan Stock Option Agreement

from 8-K 9 pages Warrant Agreement

from S-8 ~10 pages 2003 Equity Incentive Plan